On June 12, 2012, Cornell researchers David Nanus, Brian Kirby and Paraskevi Giannakakou discussed their new microfluidic device that collects circulating, living prostate cancer tumor cells from blood.
The research, conducted collaboratively between Cornell University and Weill Cornell Medical College, aims toward tailoring cancer treatment and improving patient survival. Click below to view the presentation.
What's New in GU? 